Oncology

Latest News

FDA expands nivolumab approval to treat adolescents with stage IIB/C melanoma | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA expands nivolumab approval to treat adolescents with Stage IIB/C melanoma

October 16th 2023

Patients aged 12 years and up with completely resected Stage IIB/C melanoma can now be treated (adjuvant) with FDA-approved nivolumab (Opdivo; Bristol Meyers Squibb Company).

For children with leukemia or lymphoma, what does a pediatrician need to know?
For children with leukemia or lymphoma, what does a pediatrician need to know?

July 26th 2023

Ultrasound radiomics for predicting extrathyroidal extension in children
Ultrasound radiomics for predicting extrathyroidal extension in children

February 28th 2023

Prenatal teledentistry: because oral-systemic health links begin in the womb
Prenatal teledentistry: because oral-systemic health links begin in the womb

October 28th 2022

Approval in Paroxysmal Nocturnal Hemoglobinuria With Pediatric Indication
Approval in Paroxysmal Nocturnal Hemoglobinuria With Pediatric Indication

September 9th 2021

Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Navigating a New Era of Food Allergy Management

Register Now!

ACCC 50th Annual Meeting & Cancer Center Business Summit (AMCCBS): Clinical Updates from San Diego on Hematologic Malignancies

Register Now!

Clinical Vignettes: Inaugural International Congress on Pediatric Oncology

View More

FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates

View More

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Medical Crossfire®: How Has the Nurse’s Role Evolved in the Management of Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas?

View More

2nd Annual International Congress on Pediatric Oncology

View More

More News

© 2023 MJH Life Sciences

All rights reserved.